Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine-Reference-Cited by-同舟云学术

Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine

Published:2004-05 Issue:5 Volume:44 Page:414-425
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache

Author:

Dodick David,Lipton Richard B.,Martin Vincent,Papademetriou Vasilios,Rosamond Wayne,MaassenVanDenBrink Antoinette,Loutfi Hassan,Welch K.Michael,Goadsby Peter J.,Hahn Steven,Hutchinson Susan,Matchar David,Silberstein Stephen,Smith Timothy R.,Purdy R. Allan,Saiers Jane,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1526-4610.2004.04078.x/fullpdf

Reference66 articles.

1. Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II

2. The Global Burden of Disease Study

3. Migraine — Current Understanding and Treatment

4. Migraine Diagnosis and Treatment: Results From the American Migraine Study II

Cited by 300 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonists;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease;Mayo Clinic Proceedings;2024-08

3. Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine;Headache: The Journal of Head and Face Pain;2024-05-27

4. Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile;Biological Psychiatry: Cognitive Neuroscience and Neuroimaging;2024-05

5. Triptan use in elderly over 65 years and the risk of hospitalization for serious vascular events;The Journal of Headache and Pain;2024-04-26